Volume 9 (2022): Issue 1

The Cinderella Study: women's lived experience of bleeding disorders – CSL Behring Symposium

Open Access | | Creative Commons Attribution NonCommercial NoDerivatives
Debra Pollard ORCID iD
Kate Khair ORCID iD

Abstract

Abstract

Many of the experiences described by women 20 years ago remain prevalent today, and healthcare provision needs to change to offer better treatment and support to women in the bleeding disorder community. These were the key findings of the recently published Cinderella study, which explored the lived experience of women who bleed due to a diagnosed bleeding disorder in order to improve understanding of their unmet needs. Following a systematic literature review to establish what previous research had been carried out in women with bleeding disorders, the Cinderella study undertook an online survey and in-depth discussions (focus groups and one-to-one interviews) to further explore the lived experiences of women haemophilia carriers (WHC), women with a diagnosed bleeding disorder (WBD) and women with immune thrombocytopenia (WITP). The study demonstrated the significant impact of bleeding disorders on the daily lives of survey respondents and the challenges of accessing specialist support, particularly for WHCs. Themes discussed included difficulty obtaining a diagnosis, lack of awareness amongst and poor communication from HCPs, stress and anxiety, coping strategies and sources of support.

Article

View Full Article

References

  • 1. Holdcroft A. Gender bias in research: how does it affect evidence based medicine? J R Soc Med 2007; 100(1): 2–3. doi: https://doi.org/10.1258/jrsm.1001.1.2.
  • 2. Liu KA, Dipietro Mager NA. Women's involvement in clinical trials: historical perspective and future implications. Pharmacy Practice 2016; 14(1): 708. doi: https://doi.org/10.18549/PharmPract.2016.01.708.
  • 3. Sundari Ravindran T, Teerawattananon Y, Tannenbaum C, Vijayasingham L. Making pharmaceutical research and regulation work for women. BMJ 2020; 371: m3808. doi: https://doi.org/10.1136/bmj.m3808.
  • 4. Mirin AA. Gender disparity in the funding of diseases by the U.S. National Institutes of Health. J Women's Health (Larchmt) 2021; 30(7): 956–963. doi: https://doi.org/10.1089/jwh.2020.8682.
  • 5. Weyand AC, James PD. Sexism in the management of bleeding disorders. Res Pract Thromb Haemost 2021; 5(1): 51–54. doi: https://doi.org/10.1002/rth2.12468.
  • 6. Kadir RA, Sabin CA, Pollard D, Lee CA, Economides DL. Quality of life during menstruation in patients with inherited bleeding disorders. Haemophilia 1998; 4(6): 836–41. doi: https://doi.org/10.1046/j.1365-2516.1998.00208.x.
  • 7. Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998; 351 (9101): 485–9. doi: https://doi.org/10.1016/S0140-6736(97)08248-2.
  • 8. Kadir RA, Economides DL, Sabin CA, Pollard D, Lee CA. Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders. Haemophilia 1999; 5(1): 40–8. doi: https://doi.org/10.1046/j.1365-2516.1999.00285.x.
  • 9. Khair K, Holland M, Pollard D. The experience of girls and young women with inherited bleeding disorders. Haemophilia 2013; 19(5): e276–81. doi: https://doi.org/10.1111/hae.12155.
  • 10. Sanigorska A, Chaplin S, Holland M, Khair K, Pollard D. The lived experience of women with a bleeding disorder: A systematic review. Res Pract Thromb Haemost 2022; 6: e12652. doi: https://doi.org/10.1002/rth2.12652.
  • 11. Khair K, Pollard D, Steadman L, Jenner K, Chaplin S. The views of women with bleeding disorders: Results from the Cinderella study. Haemophilia 2022; 28: 316–325. doi: https://doi.org/10.1111/hae.14514.
  • 12. Noone D, Skouw-Rasmussen N, Lavin M, van Galen KPM, Kadir RA. Barriers and challenges faced by women with congenital bleeding disorders in Europe: Results of a patient survey conducted by the European Haemophilia Consortium. Haemophilia 2019; 25(3): 468–474. doi: https://doi.org/10.1111/hae.13722.
  • 13. van Galen K, Lavin M, Skouw-Rasmussen N, et al. Clinical management of women with bleeding disorders: A survey among European haemophilia treatment centres. Haemophilia 2020; 26(4): 657–662. doi: https://doi.org/10.1111/hae.14043.
  • 14. Presky KO, Kadir RA. Women with inherited bleeding disorders – Challenges and strategies to improved care. Thromb Res 2020; 196: 569–578. doi: https://doi.org/10.1016/j.thromres.2019.07.004.
  • 15. Arya S, Wilton P, Page D, et al. “They don’t really take my bleeds seriously”: Barriers to care for women with inherited bleeding disorders. J Thromb Haemost 2021; 19(6): 1506–1514. doi: https://doi.org/10.1111/jth.15311.
  • 16. Byams VR, Miller CH, Bethea FM, et al. Bleeding disorders in women and girls: state of the science and CDC Collaborative Programs. J Women's Health 2022; 31(3): 301–309. doi: https://doi.org/10.1089/jwh.2022.0008.
  • 17. van Galen K, d’Oiron R, James P, et al. A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH. J Thromb Haemost 2021; 19(8): 1883–1887. doi: https://doi.org/10.1111/jth.15397.
  • 18. van Galen K, Lavin M, Skouw-Rasmussen N, et al.; the European Haemophilia Consortium (EHC) and the European Association for Haemophilia and Allied Bleeding Disorders (EAHAD). European principles of care for women and girls with inherited bleeding disorders. Haemophilia 2021; 27(5): 837–847. doi: https://doi.org/10.1111/hae.14379.

PDF Download

Download PDF

Open in full-page viewer

Authors